Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Morser

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Current Drug Targets|December 31, 2011
Thrombomodulin links coagulation to inflammation and immunityJohn Morser
Arteriosclerosis, Thrombosis, and Vascular Biology|January 22, 2005
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expressionHideyuki Migita, John Morser
Ebiomedicine|April 15, 2016
Plasmin as a complement C5 convertaseLawrence L Leung, John Morser
Stem Cells (Dayton, Ohio)|April 26, 2005
The Promises and Challenges of Regenerative Medicine, October 20-22, 2004, Kobe, JapanJohn Morser, Fiona M McDonald
FEBS Letters|March 12, 2004
Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cellsHideyuki Migita, John Morser, Kohichi Kawai
Cancers|July 14, 2023
Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune ResponseLawrence L Leung, Timothy Myles, John Morser
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2023
Methods to Investigate Thrombin Cleavage of Osteopontin (OPN)Lei Zhao, Lawrence L Leung, John Morser
Biomedicines|August 26, 2022
Chemerin Forms: Their Generation and ActivityLei Zhao, Lawrence L Leung, John Morser
The Journal of Biological Chemistry|August 13, 2014
Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragmentZhifei Shao, John Morser, Lawrence L K Leung
The Journal of Biological Chemistry|June 12, 2003
Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificityLei Zhao, Brad Buckman, Marian Seto, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Current Drug Targets|December 31, 2011
Thrombomodulin links coagulation to inflammation and immunityJohn Morser
Arteriosclerosis, Thrombosis, and Vascular Biology|January 22, 2005
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expressionHideyuki Migita, John Morser
Ebiomedicine|April 15, 2016
Plasmin as a complement C5 convertaseLawrence L Leung, John Morser
Stem Cells (Dayton, Ohio)|April 26, 2005
The Promises and Challenges of Regenerative Medicine, October 20-22, 2004, Kobe, JapanJohn Morser, Fiona M McDonald
FEBS Letters|March 12, 2004
Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cellsHideyuki Migita, John Morser, Kohichi Kawai
Cancers|July 14, 2023
Thrombin Cleavage of Osteopontin and the Host Anti-Tumor Immune ResponseLawrence L Leung, Timothy Myles, John Morser
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2023
Methods to Investigate Thrombin Cleavage of Osteopontin (OPN)Lei Zhao, Lawrence L Leung, John Morser
Biomedicines|August 26, 2022
Chemerin Forms: Their Generation and ActivityLei Zhao, Lawrence L Leung, John Morser
The Journal of Biological Chemistry|August 13, 2014
Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragmentZhifei Shao, John Morser, Lawrence L K Leung
The Journal of Biological Chemistry|June 12, 2003
Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificityLei Zhao, Brad Buckman, Marian Seto, et al.
Pageof 9